ACETAMINOPHEN, ASPIRIN AND CAFFEINE Drug Patent Profile
✉ Email this page to a colleague
When do Acetaminophen, Aspirin And Caffeine patents expire, and what generic alternatives are available?
Acetaminophen, Aspirin And Caffeine is a drug marketed by Aurobindo Pharma Ltd, Granules, and Perrigo. and is included in three NDAs.
The generic ingredient in ACETAMINOPHEN, ASPIRIN AND CAFFEINE is acetaminophen; aspirin; caffeine. There are sixty-six drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the acetaminophen; aspirin; caffeine profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ACETAMINOPHEN, ASPIRIN AND CAFFEINE?
- What are the global sales for ACETAMINOPHEN, ASPIRIN AND CAFFEINE?
- What is Average Wholesale Price for ACETAMINOPHEN, ASPIRIN AND CAFFEINE?
Summary for ACETAMINOPHEN, ASPIRIN AND CAFFEINE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 40 |
| Clinical Trials: | 7 |
| DailyMed Link: | ACETAMINOPHEN, ASPIRIN AND CAFFEINE at DailyMed |
US Patents and Regulatory Information for ACETAMINOPHEN, ASPIRIN AND CAFFEINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | acetaminophen; aspirin; caffeine | TABLET;ORAL | 211695-001 | Feb 2, 2022 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Granules | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | acetaminophen; aspirin; caffeine | TABLET;ORAL | 214039-001 | Feb 23, 2021 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Perrigo | ACETAMINOPHEN, ASPIRIN AND CAFFEINE | acetaminophen; aspirin; caffeine | TABLET;ORAL | 075794-001 | Nov 26, 2001 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
